Special collections

A signature for pan-cancer prognosis based on neutrophil extracellular traps
Yi Zhang, Liping Guo, Qichen Dai, Bingqing Shang, Ting Xiao, Xuebing Di, Kaitai Zhang, Lin Feng, Jianzhong Shou, Yipeng Wang

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004210; DOI: 10.1136/jitc-2021-004210
Vaccines for immunoprevention of DNA mismatch repair deficient cancers
Alejandro Hernandez-Sanchez, Mark Grossman, Kevin Yeung, Shizuko S Sei, Steven Lipkin, Matthias Kloor

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004416; DOI: 10.1136/jitc-2021-004416
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer
Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill, Hiba Dada, Regina Resta, Stephanie Wagner, Naomi Fei, Pashtoon Murtaza Kasi

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004485; DOI: 10.1136/jitc-2021-004485
iRECIST and atypical patterns of response to immuno-oncology drugs
Jorge Luis Ramon-Patino, Sabine Schmid, Sally Lau, Lesley Seymour, Pierre-Olivier Gaudreau, Janice Juan Ning Li, Penelope Ann Bradbury, Emiliano Calvo

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004849; DOI: 10.1136/jitc-2022-004849
Correction: High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004197corr1; DOI: 10.1136/jitc-2021-004197corr1
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel
Francesca Spada, Paolo Bossi, Corrado Caracò, Vanna Chiarion Sileni, Angelo Paolo Dei Tos, Nicola Fazio, Giovanni Grignani, Michele Maio, Pietro Quaglino, Paola Queirolo, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004742; DOI: 10.1136/jitc-2022-004742
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade
Michal Harel, Coren Lahav, Eyal Jacob, Nili Dahan, Itamar Sela, Yehonatan Elon, Shani Raveh Shoval, Galit Yahalom, Iris Kamer, Alona Zer, Ofer Sharon, David P Carbone, Adam P Dicker, Jair Bar, Yuval Shaked

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004582; DOI: 10.1136/jitc-2022-004582
Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer
Miguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, Ila J Datar, Mari Mino-Kenudson, German Corredor, Cristian Barrera, Lindsey Behlman, David L Rimm, Roy S Herbst, Anant Madabhushi, Jonathan W Riess, Vamsidhar Velcheti, Matthew D Hellmann, Justin Gainor, Kurt A Schalper

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004440; DOI: 10.1136/jitc-2021-004440
Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004291corr1; DOI: 10.1136/jitc-2021-004291corr1
Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration
Emily F Higgs, Riyue Bao, Ken Hatogai, Thomas F Gajewski

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004797; DOI: 10.1136/jitc-2022-004797

Main menu

Special collections

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Special collections

Pages